Clinical case of toxic epidermal necrolysis (Lyell's syndrome) in pediatric practice
https://doi.org/10.29001/2073-8552-2025-40-2-176-182
Abstract
A clinical case of toxic epidermal necrolysis (TEN) in a pediatric patient is presented as a severe pathological process occurring with widespread skin lesions and erosive lesions of the mucous membranes. TEN develops more often as an allergic reaction in response to drugs, the triggers maybe pathogens of infectious diseases. A drug-induced disease may occur in the practice of a pediatrician. To improve the prognosis, timely diagnosis and the use of an individual treatment protocol are important. The presented clinical case confirms the importance of timely diagnosis and early initiation of individual therapy.
About the Authors
G. D. Alemanova
Orenburg State Medical University
Russian Federation
Russian Federation
Galina D. Alemanova, Dr. Sci. (Med.), Professor, Department of Children's Diseases
build. 6, Sovetskaya str., Orenburg city, 460014
L. Yu. Popova
Orenburg State Medical University
Russian Federation
Russian Federation
Larisa Yu. Popova, Dr. Sci. (Med.), Professor, Head of the Department of Children's Diseases
build. 6, Sovetskaya str., Orenburg city, 460014
O. V. Kirichenko
Orenburg State Medical University
Russian Federation
Russian Federation
Olga V. Kirichenko, Assistant Professor, Department of Children's Diseases
build. 6, Sovetskaya str., Orenburg city, 460014
E. I. Pogrebnova
Regional Children's Clinical Hospital
Russian Federation
Russian Federation
Elena I. Pogrebnova, Allergist-immunologist of the highest category
22, str. Garankina str., Orenburg city, 460060
References
1. Lutkova Т., Karzakova L., Ukhterova N., Zhuravleva N., Andreeva N., Kudryashov S. et al. Description of a clinical case of Lyell's syndrome in a child. Acta medica Eurasica. 2019;(3):15–23. (In Russ.). URL: http://acta-medica-eurasica.ru/single/2019/3/3 (04.03.2025).
2. Tezjaeva S.A., Mlinnik R.A., Degtjareva S.F., Vagitova T.V., Nikol'skij V.O. Sindrom Lajella kak redkoe oslozhnenie medikamentoznoj terapii. Zhurnal MediAl'. 2015; 2(16): 42–45.(In Russ).
3. Zhernosek V.F., Djubkova T.P. Klinicheskaja klassifikacija i kriterii diagnostiki sindroma Stivensa – Dzhonsona – toksicheskogo jepidermal'nogo nekroliza u detej: obzor inostrannoj literatury. Pediatrija. Vostochnaja Evropa. 2014;5(1):118–133.(In Russ.).
4. Hsu D.Y., Brieva J., Silverberg N.B., Paller A.S., Silverberg J.I. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J. Am. Acad. Dermatol. 2017;76(5):811–817. https://doi.org/10.1016/j.jaad.2016.12.024
5. Ilyina N.I., Latysheva T.V., Myasnikova T.N., Luss L.V., Kurbacheva O.M., Erokhina S.M. Drugallergy. Recommendations for clinicians (Part 2). Russian Journal of Allergy. 2013;5:27–40. (In Russ.).
6. Mezhirova N.M., Baeva S.I., Azarokova A.M. Osobennosti techenija i lechenija sindroma Lajella. Medicina neotlozhnyh sostojanij. 2011;5:36–38. (In Russ.).
7. Marxer C., Frey N., Bircher A. Survival after Stevens-Johnson Syndrome or Toxic Epidermal Necrolysis: A UK-based Cohort Study. Journal of Investigative Dermatology. 2020;141(6):1016–1022. https://doi.org/10.1016/j.jid.2020.09.034
8. Downey A., Jackson C., Harun N., Cooper A. Toxic epidermal necrolysis: Review of pathogenesis and management. Journal of the American Academy of Dermatology. 2012;66(6):995–1003. https://doi.org/10.1016/j.jaad.2011.09.029
9. Fakoya A.O.J., Omenyi P., Anthony P. et al. Stevens – Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of DrugInduced Etiologies, and Possible Therapeutic Modalities. Open Access Maced. J. Med. Sci..2018; 6 (4): 730–738. https://doi.org/10.3889/oamjms.2018.148
10. Schwartz R.A., McDonough P.H., Lee B.W. Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis. J. Am. Acad. Dermatol. 2013;69(2):173.e1–13; quiz 185–186. https://doi.org/10.1016/j.jaad.2013.05.003
11. Davydova Z.V., Sobolev A.V., Sokolova O.V. Layell syndrome: difficulties of diagnostics. Pediatrician (St. Petersburg). 2018;9(5):115–119. https://doi.org/10.17816/PED95115-119
12. Kharchenko G.A., Kimirilova O.G. Lyell’s syndrome in children – clinical https://d14. Ferrándiz-Pulido C., García-Fernández D., DomínguezSampedro P. et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a University Hospital. J. Eur. Acad. Dermatol. Venereol., 2011;(25):1153–1159. https://doi.org/10.1111/j.1468-3083.2010.03935.x
13. Djubkova T.P., Zhernosek V.F. Sindrom Stivensa – Dzhonsona – toksicheskij jepidermal'nyj nekroliz u detej. Minsk: RIVSh; 2013:205. (In Russ.).
14. Ferrándiz-Pulido C., García-Fernández D., DomínguezSampedro P. et al. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a University Hospital. J. Eur. Acad. Dermatol. Venereol., 2011;(25):1153–1159. https://doi.org/10.1111/j.1468-3083.2010.03935.x
15. Capule F., Tragulpiankit P., Mahasirimongkol S., Jittikoon J., Wichukchinda N., Alentajan-Aleta L.T. et al. HLA-A*24:07 as a potential biomarker for carbamazepine-induced Stevens-Johnson syndrome/ toxic epidermal necrolysis in Filipino patients. Pharmacogenomics. 2021;22(8):465–472. https://doi.org/10.2217/pgs-2020-0191
16. Bastuji-Garin S., Fouchard N., Bertocchi M., Roujeau J.C., Revuz J., Wolkenstein P. SCORTEN: A severity-of-illness score for toxic epidermal necrolysis. J. Invest. Dermatol. 2000;(115):149–153. https://doi.org/10.1046/j.1523-1747.2000.00061.x.
17. Schlienger R.G., Shapiro L.E., Shear N.H. Lamotrigine-induced severe cutaneous adverse reactions. Epilepsia. 1998;39:22–26. https://doi.org/10.1111/j.1528-1157.1998.tb01681.x
Review
For citations:
Alemanova G.D., Popova L.Yu., Kirichenko O.V., Pogrebnova E.I. Clinical case of toxic epidermal necrolysis (Lyell's syndrome) in pediatric practice. Siberian Journal of Clinical and Experimental Medicine. 2025;40(2):176-182. (In Russ.) https://doi.org/10.29001/2073-8552-2025-40-2-176-182
Views:
18
.png)
Email this article 